Skip to content

When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

PLOS BLOGS Speaking of Medicine and Health

This Week in PLOS Medicine: Atherosclerosis & Air Pollution, Non-melanoma Skin Cancer, & the Scottish Alcohol Industry

Image Credit: Flickr Jennifer Barnard
Image Credit: Flickr Jennifer Barnard

This week PLOS Medicine published articles ranging from research on the link between air pollution and atherosclerosis to a case study of the Scottish alcohol industry’s effect on public policy.

In a prospective cohort study, Sara Adar and colleagues found that decreasing levels of fine particulate matter in multiple US urban areas are associated with slowed progression of intima-medial thickness, a surrogate measure of atherosclerosis. Nino Künzli contextualized these findings as some of the first human evidence for the impact of air pollution on the development of atherosclerosis.

In a prospective study, Jiali Han and colleagues found a modestly increased risk of subsequent malignancies among individuals with a history of non-melanoma skin cancer, specifically breast and lung cancer in women and melanoma in both men and women.

Jim McCambridge and colleagues analyzed industry submissions to a Scottish Government consultation on whole population approaches to alcohol policy. The authors noted that studies of the nature of alcohol industry and other corporate influences on public policies can be informed by work already conducted on the tobacco industry.

In honor of the WHO’s World Immunization Week, the PLOS Medicine homepage features a selection of recent research and policy articles on vaccination.

Remember you can comment on, annotate and rate any PLOS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.


Leave a Reply

Your email address will not be published. Required fields are marked *

Add your ORCID here. (e.g. 0000-0002-7299-680X)

Back to top